2016;139:1391-401. Oka Y, Tsuboi A, Elisseeva OA, et al. WT1 as a novel target antigen for cancer immunotherapy. Curr Cancer Drug Targets. 2002;2:45 -54. Oka Y, Tsuboi A, Taguchi T, et al. Induction of WT1 (Wilms' tumor gene) -specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA.